-
Product Insights
Likelihood of Approval Analysis for Open-Angle Glaucoma
Overview How likely is it that the drugs in Open-Angle Glaucoma will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Open-Angle Glaucoma Overview Open-angle glaucoma is a chronic eye condition characterized by...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Bimatoprost Grenod in Open-Angle Glaucoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Bimatoprost Grenod in Open-Angle Glaucoma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Bimatoprost Grenod in Open-Angle Glaucoma Drug Details: Bimatoprost grenod (NCX-470) is...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Sepetaprost in Ocular Hypertension
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Sepetaprost in Ocular Hypertension report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Sepetaprost in Ocular Hypertension Drug Details: Sepetaprost (DE-126) is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Sepetaprost in Open-Angle Glaucoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Sepetaprost in Open-Angle Glaucoma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Sepetaprost in Open-Angle Glaucoma Drug Details: Sepetaprost (DE-126) is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – AGN-193408 SR in Ocular Hypertension
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - AGN-193408 SR in Ocular Hypertension report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. AGN-193408 SR in Ocular Hypertension Drug Details: AGN-193408 SR is...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – AGN-193408 SR in Open-Angle Glaucoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - AGN-193408 SR in Open-Angle Glaucoma report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. AGN-193408 SR in Open-Angle Glaucoma Drug Details: AGN-193408 SR is...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Cenegermin in Keratoconjunctivitis Sicca (Dry Eye)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Cenegermin in Keratoconjunctivitis Sicca (Dry Eye) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Cenegermin in Keratoconjunctivitis Sicca (Dry Eye) Drug Details: Cenegermin (Oxervate)...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Cenegermin in Sicca Syndrome (Sjogren)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Cenegermin in Sicca Syndrome (Sjogren) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Cenegermin in Sicca Syndrome (Sjogren) Drug Details: Cenegermin (Oxervate) is a...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Aldafermin in Constipation
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Aldafermin in Constipation report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Aldafermin in Constipation Drug Details: Aldafermin (NGM-282) is under development for the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – VX-548 in Post-Operative Pain
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - VX-548 in Post-Operative Pain report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. VX-548 in Post-Operative Pain Drug Details: VX-548 is under development for...